Angiotensin II and the Endothelium
- 1 February 2005
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 45 (2), 163-169
- https://doi.org/10.1161/01.hyp.0000153321.13792.b9
Abstract
The initial view of the renin-angiotensin system focused on the role of angiotensin II as a hormone involved in blood pressure control, based on its role in renal salt and water regulation, as well as central nervous system (thirst) and vascular smooth muscle tone. Subsequent data showed a role for angiotensin II in long-term effects on cardiovascular structure, including cardiac hypertrophy and vascular remodeling. Importantly, recent human studies with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have demonstrated exciting clinical benefits including decreases in incidence of stroke, diabetes, and end-stage renal disease that suggest important new mechanisms of action. In this review, we focus on new roles for the renin-angiotensin system in the endothelium based on the concepts of diverse signals and effects mediated by multiple angiotensin I- and angiotensin II-derived peptides, multiple angiotensin metabolizing enzymes, multiple receptors, and vascular bed-specific intracellular signals.Keywords
This publication has 47 references indexed in Scilit:
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Differential regulation of in vivo angiogenesis by angiotensin II receptorsThe FASEB Journal, 2003
- Mice Lacking Endothelial ACEHypertension, 2003
- ACE Inhibition Versus Angiotensin Type 1 Receptor AntagonismHypertension, 2002
- Antiangiogenic Effect of Angiotensin II Type 2 Receptor in Ischemia-Induced Angiogenesis in Mice HindlimbCirculation Research, 2002
- Upregulation of LOX-1 Expression in Aorta of Hypercholesterolemic Rabbits: Modulation by LosartanBiochemical and Biophysical Research Communications, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- Effects of Quinapril on Coronary Blood Flow in Coronary Artery Disease Patients With Endothelial DysfunctionThe American Journal of Cardiology, 1997
- Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidneyKidney International, 1994
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987